New research uncovers how cancer-induced nerve injury drives resistance to anti-PD-1 therapy, revealing potential strategies to enhance treatment efficacy.
Tiny, three-dimensional organoid models are reshaping cancer research by recreating the intricate architecture and diversity ...
In a recently published study, researchers at Fox Chase Cancer Center revealed for the first time that cancer cells can evade anti-cancer drugs by entering and surviving within bone marrow fibroblasts ...
Results from OVATION 2 Study reinforce IMNN-001 efficacy benefits observed in the clinic and unique mechanism of action, producing key ...
Rakesh Jain, Ph.D., director of the Edwin Steele Laboratories for Tumor Biology in the Department of Radiation Oncology at ...
NIH award of $2.25M funds preclinical studies that will advance Targefrin toward clinical trials for pancreatic cancer ...
Tempest Therapeutics presents new data on amezalpat's immune response at the 2025 AACR Annual Meeting, highlighting its cancer treatment potential. Tempest Therapeutics, Inc. announced new data at the ...
Imagine that two women have breast cancer with the same subtype: hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-). They’re the same age, weight, and height ...
New research from Edith Cowan University shows that a single bout of weight training or HIIT can boost anti-cancer myokines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback